{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:44:18Z","timestamp":1792226658599,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jns.2017.02.024","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T15:16:07Z","timestamp":1486653367000},"page":"275-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Malignancy in Guillain-Barr\u00e9 syndrome: A twelve-year single-center study"],"prefix":"10.1016","volume":"375","author":[{"given":"Fu Liong","family":"Hiew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf A.","family":"Rajabally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.02.024_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/1097-0142(196502)18:2<157::AID-CNCR2820180206>3.0.CO;2-Y","article-title":"The Guillain-Barr\u00e9 syndrome associated with cancer","volume":"18","author":"Klingon","year":"1965","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2017.02.024_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00415-004-0317-3","article-title":"Risk of cancer in patients with Guillain-Barre syndrome (GBS)","volume":"251","author":"Vigliani","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.02.024_bb0015","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1097-4598(200012)23:12<1800::AID-MUS3>3.0.CO;2-X","article-title":"Paraneoplastic syndromes of the spinal cord, nerve, and muscle","volume":"23","author":"Rudnicki","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2017.02.024_bb0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.02.024_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain-Barr\u00e9 and Miller Fisher syndromes\u2013new diagnostic classification","volume":"10","author":"Wakerley","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2017.02.024_bb0030","unstructured":"Cancer U.K. http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics July 2016."},{"key":"10.1016\/j.jns.2017.02.024_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.02.024_bb0040","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1468-1331.2007.01990.x","article-title":"Pure motor relapsing Guillain\u2013Barr\u00e9 syndrome associated with anti-GM1 antibodies revealing urinary bladder cancer","volume":"17","author":"Lagrange","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2017.02.024_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1743-7563.2011.01493.x","article-title":"Guillain-Barr\u00e9 syndrome in colorectal cancer","volume":"8","author":"Vatandoust","year":"2012","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.jns.2017.02.024_bb0050","first-page":"86","article-title":"Antibodies against GM1 gangliosides associated with metastatic melanoma","volume":"21","author":"Nicolae","year":"2012","journal-title":"Acta Dermatovenerol. Croat."},{"key":"10.1016\/j.jns.2017.02.024_bb0055","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.02.024_bb0060","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ajh.24171","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"90","author":"Dispenzieri","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jns.2017.02.024_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.wco.0000173462.17135.ee","article-title":"Paraneoplastic syndromes of the peripheral nerves","volume":"18","author":"Rudnicki","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2017.02.024_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jnnp.74.4.507","article-title":"Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma","volume":"74","author":"Kloos","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.02.024_bb0075","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.02.024_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000338296","article-title":"A case of paraneoplastic demyelinating motor polyneuropathy","volume":"4","author":"Mostoufizadeh","year":"2012","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jns.2017.02.024_bb0085","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2169\/internalmedicine.53.2098","article-title":"Occam's Razor or Hickam's dictum: a paraneoplastic or coincidental occurrence of lung cancer and Guillain-Barr\u00e9 syndrome","volume":"53","author":"Watanuki","year":"2014","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2017.02.024_bb0090","first-page":"878","article-title":"A patient of sensorimotor neuropathy with small cell lung carcinoma and anti-GM1 antibody","volume":"42","author":"Itou","year":"2002","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jns.2017.02.024_bb0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2004.07.020","article-title":"Gangliosides act as onconeural antigens in paraneoplastic neuropathies","volume":"156","author":"De Toni","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2017.02.024_bb0100","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/jnnp.2003.032193","article-title":"Antiganglioside antibodies in paraneoplastic peripheral neuropathies","volume":"75","author":"Antoine","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.02.024_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ane.12459","article-title":"Hyponatraemia in Guillain-Barr\u00e9 syndrome revisited","volume":"133","author":"Hiew","year":"2016","journal-title":"Acta Neurol. Scand."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T06:48:49Z","timestamp":1530600529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1730120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":21,"alternative-id":["S0022510X1730120X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.02.024","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignancy in Guillain-Barr\u00e9 syndrome: A twelve-year single-center study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}